You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nod-positive prostate cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer, Recurrent Prostate Cancer, PET Positive Trial run by the National Cancer Institute (NCI) (Enzalutamide, M9241)

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 27, 2023

Castration-Resistant Prostatic Cancer Trial ([Lu-177]-PNT2002)

Available
  • Castration-Resistant Prostatic Cancer
  • (no location specified)
Sep 11, 2023

Oligometastatic Prostate Cancer (OMPC) Trial (AAA617)

Not yet recruiting
  • Oligometastatic Prostate Cancer (OMPC)
  • (no location specified)
Jul 3, 2023

Prostate-Specific Membrane Antigen (PSMA) Radionuclide Therapy

Recruiting
  • PSMA-positive Metastatic Castration-resistant Prostate Cancer Treated With PSMA Radionuclide Therapy
  • PSMA radionuclide therapy
  • Dallas, Texas
    Methodist Dallas Medical Center
Aug 9, 2023

Metastatic Castration-resistant Prostate Cancer (mCRPC) Trial (225Ac-PSMA-R2, 68Ga-PSMA-R2)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • (no location specified)
Aug 8, 2023

Advanced Prostate Cancer Trial (HRS-4357 injection)

Not yet recruiting
  • Advanced Prostate Cancer
  • HRS-4357 injection
  • (no location specified)
Aug 16, 2023

Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer Trial in

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • +2 more
  • Vancouver, British Columbia, Canada
    BC Cancer
Nov 28, 2022

Men of African Ancestry Using MRI and MRI Guided Biopsy

Not yet recruiting
  • Prostate Specific Antigens
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    May 31, 2023

    Prostate Cancer Trial in Basel (3D model guided secondary resection)

    Completed
    • Prostate Cancer
    • 3D model guided secondary resection
    • Basel, Switzerland
      Universitätsspital Basel Urologie
    Jul 17, 2023

    Malignancy Trial in Beijing (Al18F-PSMA-BCH PET/CT)

    Recruiting
    • Malignancy
    • Al18F-PSMA-BCH PET/CT
    • Beijing, Chaoyang, China
      National Cancer Center/Cancer Hospital,Chinese Academy of Medica
    Mar 7, 2023

    Optimizing Positive Predicting Value of Prostate MRI

    Enrolling by invitation
    • Prostate Cancer
    • Prostate Magnetic resonance Imaging
    • Foggia, Puglia, Italy
      university ospital: Ospedali Riiuniti di Foggia
    Jun 14, 2022

    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial (AAA617, 68Ga-PSMA-11)

    Not yet recruiting
    • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
    • (no location specified)
    Aug 16, 2023

    Prostate Disease, Elevated Prostate Specific Antigen, Family History of Prostate Cancer Trial in Lake Success, New York

    Recruiting
    • Prostate Disease
    • +4 more
    • Prostate Biopsy
    • +2 more
    • Lake Success, New York
    • +2 more
    Jan 27, 2023

    Prostatic Tumors, Castration-Resistant Trial in Darlinghurst, Pretoria (225^Ac-PSMA-617, 68^Ga-PSMA-11)

    Recruiting
    • Prostatic Neoplasms, Castration-Resistant
    • 225^Ac-PSMA-617
    • 68^Ga-PSMA-11
    • Darlinghurst, Australia
    • +1 more
    Nov 23, 2022

    Prostate Cancer Trial in Vancouver, Montreal, Quebec City (177Lu-PSMA-617, Docetaxel)

    Suspended
    • Prostate Cancer
    • Vancouver, British Columbia, Canada
    • +3 more
    Jun 13, 2022

    Prostate Cancer Trial in Sapporo city, Kanazawa-city (177Lu-PSMA-617, 68Ga-PSMA-11, Best supportive/best standard of care)

    Recruiting
    • Prostate Cancer
    • 177Lu-PSMA-617
    • +2 more
    • Kashiwa, Chiba, Japan
    • +6 more
    Jan 23, 2023

    Prostate Cancer Among Those WithPositive Family History

    Completed
    • Prostate Cancer
    • +2 more
      • Nasiriyah, Thi Qar, Iraq
        Al-Dar medical Center
      Aug 17, 2022

      Breast Cancer, HER2-negative Breast Cancer, Metastatic Breast Cancer Trial in Madison (18F-DCFPyL)

      Recruiting
      • Breast Cancer
      • +2 more
      • Madison, Wisconsin
        University of Wisconsin School of Medicine and Public Health
      Oct 18, 2022

      Prostate Cancer Trial in Québec (Pembrolizumab)

      Recruiting
      • Prostate Cancer
      • Québec, Canada
        CHU de Québec-Université Laval
      Mar 8, 2022

      Metastasis From Malignant Tumor of Prostate (Disorder) Trial in United States (64Cu-PSMA I&T)

      Recruiting
      • Metastasis From Malignant Tumor of Prostate (Disorder)
      • 64Cu-PSMA I&T
      • New Haven, Connecticut
      • +7 more
      Jan 17, 2023

      Refractory Cancer Trial in Hamburg (BIBW 2992 (Afatinib))

      Terminated
      • Refractory Cancer
      • BIBW 2992 (Afatinib)
      • Hamburg, Germany
        University Medical Center Hamburg-Eppendorf
      Jun 29, 2022

      Prostatic Tumor Trial (AAA617, AAA517, Piflufolastat F 18)

      Not yet recruiting
      • Prostatic Neoplasm
      • (no location specified)
      Apr 27, 2023

      Prostate Carcinoma Trial in Chicago (Fluorine F 18 DCFPyL, Gadobenate Dimeglumine, Gadobutrol)

      Not yet recruiting
      • Prostate Carcinoma
      • Fluorine F 18 DCFPyL
      • +6 more
      • Chicago, Illinois
        Northwestern University
      Aug 2, 2022

      Prostate Cancer Trial in Toronto (Moderate hypofractionated boost to the prostate with pelvic RT (external beam radiotherapy))

      Recruiting
      • Prostate Cancer
      • Moderate hypofractionated boost to the prostate with pelvic RT (external beam radiotherapy)
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Center
      Jul 18, 2022

      Prostate Cancer Trial in United States (Niraparib, Leuprolide, Abiraterone Acetate)

      Recruiting
      • Prostate Cancer
      • Ann Arbor, Michigan
      • +3 more
      Oct 18, 2022